On June 22, Matthias Bodenstedt, Chief Financial Officer of MoonLake Immunotherapeutics (NASDAQ:MLTX), sold 39,120 common ...
What proportion of Bodenstedt's MoonLake Immunotherapeutics stake was involved in this transaction? The sale represented 3.4% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results